Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
Aims: We aim to perform a systematic review and meta-analysis examining randomized controlled trials assessing the efficacy and safety of sacubitril/valsartan in patients on renal outcomes, in comparison with the renin–angiotensin–aldosterone system inhibitor (RAASi).Methods: Eligible studies were r...
Guardado en:
Autores principales: | Ying Xu, Yang Chen, Jia Wei Zhao, Chao Li, Amanda Y Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/293e5684ce04422d82c832ce9a2a3b46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Mohammad Abumayyaleh, et al.
Publicado: (2021) -
Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
por: M. O.E. Irhuma, et al.
Publicado: (2016) -
Angiotensin II and the Renal Hemodynamic Response to an Isolated Increased Renal Venous Pressure in Rats
por: Xiaohua Huang, et al.
Publicado: (2021) -
Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos
por: Germain A,Alfredo M, et al.
Publicado: (2002) -
Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Karl Andersen
Publicado: (2009)